Vident Investment Advisory’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Vident Investment Advisory's RGEN Position: Q1 2022 in Review
Vident Investment Advisory sold out of Repligen (RGEN) in Q1 2022, closing a stake of 4,488 shares — an estimated $1.19M sold.
Vident Investment Advisory first reported a position in RGEN in Q3 2021 and held it in 2 quarters. The position peaked at $1.19M in Q4 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.
- Vident Investment Advisory reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
- Vident Investment Advisory sold 4,488 Repligen shares in Q1 2022, an estimated $1.19M.
- Vident Investment Advisory first reported a position in Repligen in Q3 2021 and held it in 2 quarters.
- Vident Investment Advisory's Repligen position peaked at $1.19M in Q4 2021.
- 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.
Based on Vident Investment Advisory's 13F filing for Q1 2022, filed 16 May 2022.